I can only speak from the experience of being a melanoma patient. Keytruda (known as Pembrolizumab in the UK) and Opdivo (known as Nivolumab in the UK) are routinely given as treatment for Stage 4 melanoma patients and as adjuvant treatment for a year for Stage 2 & Stage 3 patients. You need to be more specific as to which type of cancer you have, for a more detailed reply to your question.

I can only speak from the experience of being a melanoma patient. Keytruda (known as Pembrolizumab in the UK) and Opdivo (known as Nivolumab in the UK) are routinely given as treatment for Stage 4 melanoma patients and as adjuvant treatment for a year for Stage 2 & Stage 3 patients. You need to be more specific as to which type of cancer you have, for a more detailed reply to your question.